abstract |
PROBLEM TO BE SOLVED: To provide an anti-CD27 antibody in the treatment of diseases such as cancer and infectious diseases. SOLUTION: Heavy chain variable region CDR1 containing a specific amino acid sequence, heavy chain variable region CDR2 containing a specific amino acid sequence, heavy chain variable region CDR3 containing a specific amino acid sequence, and light chain variable region containing a specific amino acid sequence. An antibody or antigen-binding fragment thereof that binds to anti-human CD27, comprising CDR1, a light chain variable region CDR2 containing a specific amino acid sequence, and a light chain variable region CDR3 containing a specific amino acid sequence. [Selection diagram] Fig. 7A |